Matches in Wikidata for { <http://www.wikidata.org/entity/Q59400478> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q59400478 description "im Jahr 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59400478 description "wetenschappelijk artikel" @default.
- Q59400478 description "наукова стаття, опублікована у 2014" @default.
- Q59400478 name "A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01)" @default.
- Q59400478 name "A multi-center study of high dose Aldesleukin" @default.
- Q59400478 type Item @default.
- Q59400478 label "A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01)" @default.
- Q59400478 label "A multi-center study of high dose Aldesleukin" @default.
- Q59400478 prefLabel "A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01)" @default.
- Q59400478 prefLabel "A multi-center study of high dose Aldesleukin" @default.
- Q59400478 P1433 Q59400478-CF5A146A-86F7-4ECD-B0CA-E11EB346F0E6 @default.
- Q59400478 P1476 Q59400478-1FEE77C8-7891-40F3-A266-0FB9E3540D87 @default.
- Q59400478 P2093 Q59400478-0702893E-28E4-4775-915B-CFEB3C2812DF @default.
- Q59400478 P2093 Q59400478-09178246-C3D3-45F2-87F2-548A5A3E9C8A @default.
- Q59400478 P2093 Q59400478-092E9483-FB49-460F-A7AD-E9D8E91C031B @default.
- Q59400478 P2093 Q59400478-0DF9033D-D906-47B9-B6D0-ABD578EF34D6 @default.
- Q59400478 P2093 Q59400478-26B2E127-E50D-4061-8544-8E881D8DD784 @default.
- Q59400478 P2093 Q59400478-28C9AE79-28B8-4F7E-8042-57B566DDA86D @default.
- Q59400478 P2093 Q59400478-2C028A05-22F5-4174-8106-547E49DE1A59 @default.
- Q59400478 P2093 Q59400478-4166FA72-FACF-4B2E-A63C-0A53087DA2B5 @default.
- Q59400478 P2093 Q59400478-495963EF-DE72-45A6-8CED-E69AE8B136D6 @default.
- Q59400478 P2093 Q59400478-4ABAE474-1287-46E3-B95F-AC5F816488B0 @default.
- Q59400478 P2093 Q59400478-52742758-EC1C-47F7-9284-0398C873202C @default.
- Q59400478 P2093 Q59400478-7672D90D-61D4-49ED-8C2E-EA2C7091DD6E @default.
- Q59400478 P2093 Q59400478-7D989F3C-D388-4F74-ACA8-B49B346FC181 @default.
- Q59400478 P2093 Q59400478-B095EB09-38BD-488C-B77F-E6AC26D5096E @default.
- Q59400478 P2093 Q59400478-B129B7B8-3DF0-4F62-972D-53FF99021B94 @default.
- Q59400478 P2093 Q59400478-EA6B1A88-79A6-401B-AC77-4C0A6F64487D @default.
- Q59400478 P2093 Q59400478-EEDF03E6-ED61-4692-A63F-8604AF90B675 @default.
- Q59400478 P2888 Q59400478-DEE5DC3F-CF16-4A86-B526-172E511CF26F @default.
- Q59400478 P304 Q59400478-C935AB88-382D-4EE1-A09B-9EBEF66C967E @default.
- Q59400478 P31 Q59400478-F6570D99-0525-4AE9-801E-460DEBC87BBE @default.
- Q59400478 P356 Q59400478-A780815A-2959-40A5-831A-A70DE02E3808 @default.
- Q59400478 P433 Q59400478-97EE1D01-BE7E-4CB0-9846-D4924AF1B389 @default.
- Q59400478 P478 Q59400478-96EDEA27-2B09-4581-A4C1-BD20585E23BC @default.
- Q59400478 P50 Q59400478-A031ACA7-8A60-4657-80AE-A807085B54AF @default.
- Q59400478 P577 Q59400478-9D21772D-7EC3-4F75-92A2-47FA28E5232A @default.
- Q59400478 P6179 Q59400478-0DF4F839-AF13-4915-8878-93C087306D2F @default.
- Q59400478 P921 Q59400478-ACE911E1-786A-4D46-B10E-7E3B910B1B6C @default.
- Q59400478 P932 Q59400478-4C989DE2-64B6-44E0-94B8-B708F1A358DA @default.
- Q59400478 P356 2051-1426-2-S3-P77 @default.
- Q59400478 P1433 Q27725163 @default.
- Q59400478 P1476 "A multi-center study of high dose Aldesleukin (Proleukin(HD IL-2) + Vemurafenib Zelboraf) therapy in patients with BRAFmutation positive metastatic melanoma (proclivity 01)" @default.
- Q59400478 P2093 "Brendan Curti" @default.
- Q59400478 P2093 "Bret Taback" @default.
- Q59400478 P2093 "Christopher D Lao" @default.
- Q59400478 P2093 "David Lawson" @default.
- Q59400478 P2093 "Gerald Militello" @default.
- Q59400478 P2093 "Gregory Daniels" @default.
- Q59400478 P2093 "Henry Koon" @default.
- Q59400478 P2093 "James Lowder" @default.
- Q59400478 P2093 "Joseph Clark" @default.
- Q59400478 P2093 "Lawrence Flaherty" @default.
- Q59400478 P2093 "Lee Cranmer" @default.
- Q59400478 P2093 "Marc Ernstoff" @default.
- Q59400478 P2093 "Mohammed Milhem" @default.
- Q59400478 P2093 "Sandra Aung" @default.
- Q59400478 P2093 "Sanjiv Agarwala" @default.
- Q59400478 P2093 "Theodore F Logan" @default.
- Q59400478 P2093 "Venkatesh Rudrapatna" @default.
- Q59400478 P2888 2051-1426-2-s3-p77 @default.
- Q59400478 P304 "P77-P77" @default.
- Q59400478 P31 Q13442814 @default.
- Q59400478 P356 "10.1186/2051-1426-2-S3-P77" @default.
- Q59400478 P433 "Suppl 3" @default.
- Q59400478 P478 "2" @default.
- Q59400478 P50 Q92509437 @default.
- Q59400478 P577 "2014-01-01T00:00:00Z" @default.
- Q59400478 P6179 "1013094338" @default.
- Q59400478 P921 Q18975855 @default.
- Q59400478 P932 "4288741" @default.